Steven R. Foland Joins the Board of Directors of VeriChip Corporation

DELRAY BEACH, FL – February 25, 2008 –VeriChip Corporation (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, today announced it has added Steven R. Foland to its Board of Directors. Foland is the former managing director and head of investment banking at Merriman Curhan Ford & Co, the lead underwriter of VeriChip’s initial public offering which was completed in February 2007. Foland, who began his career as an attorney, brings approximately 15 years of investment banking experience to VeriChip with firms including Morgan Stanley and Credit Suisse.

About VeriChip

VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.

For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.